查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595412

肺炎鏈球菌檢測市場：按方法、技術、產品類型和最終用戶分類 - 2025-2030 年全球預測

Pneumococcal Testing Market by Method (Immunodiagnostics, Molecular Diagnostic, Point of Care Testing), Technology (Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry), Product Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肺炎球菌檢測市場價值為16.6億美元，預計到2024年將達到18億美元，複合年成長率為8.99%，預計到2030年將達到30.3億美元。

肺炎球菌檢測包括多種旨在檢測肺炎球菌引起的感染疾病的診斷方法。肺炎球菌是一種在世界各地引起顯著發病率和死亡率的細菌，特別是在幼兒和老年人中。肺炎球菌檢測的需求源自於需要及時、準確的檢測，以幫助做出適當的治療決策，從而減少併發症並改善公共衛生結果。肺炎球菌檢測主要在臨床環境、醫院和診斷實驗室進行，快速診斷有助於加快治療速度、為疫苗策略提供資訊並監測抗生素抗藥性菌株的傳播。主要最終使用者包括醫療保健提供者、政府機構和研究機構。根據市場洞察，顯著成長是由肺炎和敗血症發病率上升、診斷技術的技術進步以及全球意識和醫療基礎設施投資的提高所推動的。就地檢驗和即時PCR的出現透過提供高精度和快速結果推動了市場擴張。疾病流行率高且診斷服務匱乏的新興市場蘊藏大量商機。透過經濟高效、易於使用的測試解決方案進入這些市場可以顯著增加市場佔有率。然而，先進診斷技術的高成本、監管挑戰以及低度開發地區缺乏認知等因素限制了市場成長。技術壁壘和對技能人才的需求也是挑戰。創新領域在於開發具有成本效益、快速且多重的診斷測試，以及提高預防感染的疫苗血清型覆蓋率。生物技術公司和政府衛生機構在研究經費和政策制定方面的合作可望擴大市場。市場競爭激烈，需要不斷的研究和創新來區分產品並有效滿足不斷變化的醫療保健需求。

主要市場統計
基準年[2023] 16.6億美元
預測年份 [2024] 18億美元
預測年份 [2030] 30.3億美元
複合年成長率（%） 8.99%

市場動態：快速發展的肺炎球菌檢測市場的關鍵市場洞察

供需的動態交互作用正在改變肺炎球菌檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 隨著早期診斷和治療的改善，肺炎球菌檢測的採用率提高
    • 肺炎鏈球菌疾病的盛行率迅速增加
    • 正在進行的疫苗和藥物分子開發臨床試驗
  • 市場限制因素
    • 開發肺炎球菌檢測方法的高成本
  • 市場機會
    • POC 測試日益普及
    • 增加研發投入並推動體外診斷（IVD）檢測技術
  • 市場挑戰
    • 缺乏專家

波特五力：駕馭肺炎鏈球菌檢測市場的策略工具

波特的「五力」框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肺炎鏈球菌檢測市場的外部影響

外部宏觀環境因素在塑造肺炎球菌檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解肺炎鏈球菌檢測市場的競爭狀況

對肺炎球菌測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣肺炎鏈球菌檢測市場供應商的績效評估

FPNV定位矩陣是評估肺炎鏈球菌檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了肺炎球菌檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，肺炎球菌檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於早期診斷和治療的改善，肺炎球菌檢測的採用率有所提高
      • 肺炎鏈球菌感染人數迅速增加
      • 疫苗和藥物分子開發的臨床試驗正在進行中
    • 抑制因素
      • 開發肺炎球菌檢測方法的高成本
    • 機會
      • POC 測試日益普及
      • 加大研發投入，體外診斷（IVD）檢測技術取得進展
    • 任務
      • 缺乏專家
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 肺炎鏈球菌檢測市場：依方法分類

  • 免疫診斷
  • 分子診斷
  • 就地檢驗

第7章肺炎鏈球菌檢測市場：依技術分類

  • 酵素免疫分析法
  • 螢光
  • 免疫組織化學
  • 基於核酸序列的擴增
  • 聚合酵素鏈鎖反應
  • 西方墨點法試驗

第8章肺炎鏈球菌檢測市場：依產品類型

  • 分析儀
  • 消耗品

第9章肺炎鏈球菌檢測市場：依最終用戶分類

  • 門診手術中心
  • 醫院/診所

第10章 北美及南美肺炎鏈球菌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太肺炎鏈球菌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的肺炎球菌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Acon Labs Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cepheid Inc.
  • F-Hoffmann la Roche Ltd.
  • Hologic, Inc.
  • Meridian Bioscience, Inc. by SD Biosensor
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
Product Code: MRR-4103B31E098A

The Pneumococcal Testing Market was valued at USD 1.66 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 8.99%, to USD 3.03 billion by 2030.

Pneumococcal testing encompasses a range of diagnostic methods aimed at detecting infections caused by Streptococcus pneumoniae, a bacterium responsible for significant morbidity and mortality worldwide, particularly among young children and the elderly. The necessity of pneumococcal testing stems from the need for timely and accurate detection that aids in appropriate treatment decisions, thereby reducing complications and improving public health outcomes. Applications of pneumococcal testing are predominantly seen in clinical settings, hospitals, and diagnostic laboratories where rapid diagnosis can expedite treatment, inform vaccination strategies, and help monitor the spread of antibiotic-resistant strains. Key end-users include healthcare providers, government entities, and research institutions. Market insights reveal significant growth influenced by rising incidences of pneumonia and sepsis, technological advancements in diagnostic techniques, and increased awareness and investment in healthcare infrastructure globally. The advent of point-of-care testing and real-time PCR is driving market expansion by offering high accuracy and swift results. Opportunities abound in emerging markets where the prevalence of disease is high but diagnostic services are underserved. Penetrating these markets with cost-effective and easy-to-use testing solutions can markedly expand market share. However, market growth faces limitations such as the high cost of advanced diagnostic technologies, regulatory challenges, and a lack of awareness in underdeveloped regions. Technological barriers and the need for skilled personnel further pose challenges. Areas of innovation lie in the development of cost-effective, rapid, and multiplexed diagnostic tests, as well as enhanced vaccine serotype coverage to preempt infection. Collaboration between biotech companies and governmental health bodies for research funding and policy making is promising for market expansion. The nature of the market is highly competitive, encouraging continuous research and innovation for companies to differentiate their products and meet evolving healthcare demands effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.66 billion
Estimated Year [2024] USD 1.80 billion
Forecast Year [2030] USD 3.03 billion
CAGR (%) 8.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumococcal Testing Market

The Pneumococcal Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
    • Upsurge in the number of prevalence of pneumococcal disease
    • Ongoing clinical trials for development of vaccines and drug molecules
  • Market Restraints
    • High cost associated with the development of pneumococcal testing methods
  • Market Opportunities
    • Rising popularity for POC tests
    • Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
  • Market Challenges
    • Dearth of professionals

Porter's Five Forces: A Strategic Tool for Navigating the Pneumococcal Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumococcal Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumococcal Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumococcal Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumococcal Testing Market

A detailed market share analysis in the Pneumococcal Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumococcal Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumococcal Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumococcal Testing Market

A strategic analysis of the Pneumococcal Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumococcal Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acon Labs Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cepheid Inc., F-Hoffmann la Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc. by SD Biosensor, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Pneumococcal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostic, and Point of Care Testing.
  • Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Nucleic Acid Sequence Based Amplification, Polymerase Chain Reaction, and Western Blot Test.
  • Based on Product Type, market is studied across Analyzers and Consumables.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of pneumococcal testing with improvement in early diagnosis and treatment
      • 5.1.1.2. Upsurge in the number of prevalence of pneumococcal disease
      • 5.1.1.3. Ongoing clinical trials for development of vaccines and drug molecules
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of pneumococcal testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising popularity for POC tests
      • 5.1.3.2. Increasing R&D investments and advancements in testing technologies for in-vitro diagnostic (IVD)
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pneumococcal Testing Market, by Method

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
  • 6.3. Molecular Diagnostic
  • 6.4. Point of Care Testing

7. Pneumococcal Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme Linked Immunosorbent Assay
  • 7.3. Immunofluorescence
  • 7.4. Immunohistochemistry
  • 7.5. Nucleic Acid Sequence Based Amplification
  • 7.6. Polymerase Chain Reaction
  • 7.7. Western Blot Test

8. Pneumococcal Testing Market, by Product Type

  • 8.1. Introduction
  • 8.2. Analyzers
  • 8.3. Consumables

9. Pneumococcal Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Americas Pneumococcal Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pneumococcal Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pneumococcal Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acon Labs Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux S.A.
  • 6. Cepheid Inc.
  • 7. F-Hoffmann la Roche Ltd.
  • 8. Hologic, Inc.
  • 9. Meridian Bioscience, Inc. by SD Biosensor
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Qiagen N.V.
  • 13. Quest Diagnostics Incorporated
  • 14. Thermo Fisher Scientific Inc.
  • 15. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. PNEUMOCOCCAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMOCOCCAL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PNEUMOCOCCAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMOCOCCAL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PNEUMOCOCCAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023